Trials / Conditions / C3 Glomerulopathy (C3G)
C3 Glomerulopathy (C3G)
3 registered clinical trials studyying C3 Glomerulopathy (C3G) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Pa NCT07483827 | eleva GmbH | Phase 1 |
| Completed | Controlled Trial Evaluating Avacopan in C3 Glomerulopathy NCT03301467 | Amgen | Phase 2 |
| Available | Managed Access Programs for LNP023, Iptacopan NCT05222412 | Novartis Pharmaceuticals | — |